药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Sibutramine
Buserelin
The risk or severity of QTc prolongation can be increased when Buserelin is combined with Lofexidine.
Sibutramine
Degarelix
The risk or severity of QTc prolongation can be increased when Degarelix is combined with Lofexidine.
Sibutramine
Pasireotide
The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Lofexidine.
Sibutramine
Cariporide
The risk or severity of QTc prolongation can be increased when Cariporide is combined with Lofexidine.
Sibutramine
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Lofexidine.
Sibutramine
Indacaterol
The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Lofexidine.
Sibutramine
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Lofexidine.
Sibutramine
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Lofexidine.
Sibutramine
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Lofexidine.
Sibutramine
Solifenacin
The risk or severity of QTc prolongation can be increased when Solifenacin is combined with Lofexidine.
Sibutramine
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Lofexidine.
Sibutramine
Arformoterol
The risk or severity of QTc prolongation can be increased when Arformoterol is combined with Lofexidine.
Sibutramine
Encainide
The risk or severity of QTc prolongation can be increased when Encainide is combined with Lofexidine.
Sibutramine
Bretylium
The risk or severity of QTc prolongation can be increased when Bretylium is combined with Lofexidine.
Sibutramine
Encorafenib
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Encorafenib.
Sibutramine
Amifampridine
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Amifampridine.
Sibutramine
Ivosidenib
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Ivosidenib.
Sibutramine
Dexverapamil
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Dexverapamil.
Sibutramine
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Dexchlorpheniramine.
Sibutramine
Lorcainide
The risk or severity of QTc prolongation can be increased when Lofexidine is combined with Lorcainide.